By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series; Caitlin Dolegowski, Marketing Specialist, LSN


Finding the right capital or channel partner is a numbers game, which means that you need to get in front of potential partners regularly. This is why the Redefining Early Stage Investments (RESI) conference takes place five times each year. You never know when a connection will surface that leads to a partnership, so you must be in the game to make it happen.
RESI is different from other partnering conferences in that it does real-time dynamic matching. The team at Life Science Nation (LSN) pre-loads investor profiles from mandates collected and stored in the LSN Investor Database. That is a big deal because (at most partnering events) investors typically have very light or even empty profiles. Because LSN has all the investors and licensing partners’ updated profiles in our database, this makes a huge difference in the quality of RESI meetings.
LSN can match based on fit, which in turn means great meetings can happen as both parties are looking for each other. Instead of booking a meeting and realizing there is no fit (which is common at other partnering conferences), RESI is unique because:
- There is the option to filter partners by capital investment and licensing mandates and match on stage of development and product.
- Most investor and licensing partner profiles are uploaded from our curated partnering database, so the user does not need to update their profile, unless they choose to, which has been a game-changer.
- Scientist-entrepreneurs and fundraising CEOs can opt to upgrade to a premier profile as part of RESI Premier Partnering to access deeper detailed investor mandates, which also include valuable contact information.
Another facet of Digital RESI March is the variety of panels focused on educating the entrepreneur on key components to partnering in the life science and health care early-stage arena. Hear straight from relevant investors and industry experts. These panels are created with the same intent and spirit of our partnering platform – To bring quality content with the early-stage life science entrepreneur in mind. Hear best practices, lessons learned, and valuable insight from our panelists. These panels are available to attendees live or their recordings are available on the meeting platform. Check out the panelists presenting at Digital RESI March below.
Tuesday, March 22, 11 AM EDT
Early-Stage Therapeutics
Bringing the Newest Therapies to the Clinic
 |
 |
 |
Yaniv Sneor
Founder
Mid Atlantic Bio Angels
(Moderator) |
Cynthia Cai, PhD, MBA
Venture Partner
Viva BioInnovator |
Catello Somma, MBA
Associate
;TVM Capital Life Science |
 |
 |
|
Scott Weiner
Partner, Amzak Health |
Sa’ar Yaniv
Director, Business Development, Fortress Biotech |
|
Tuesday, March 22, 2 PM EDT
Digital Health & Wellness
Silver-Tech Focusing on Preventative Care
 |
 |
 |
Brenda Hogan, MBA
Senior Investment Manager
Ontario Capital Growth Corporation (OCGC)
(Moderator) |
Moshe Bellows, JD
General Partner
Maccabee Ventures |
Seemant Jauhari
Managing Partner
HealthXCapital |
Tuesday, March 22, 3 PM EDT
Seed Funds
Investing in the Earliest Stage Companies
 |
 |
 |
Andy Merken
Partner & Co-Chair, Life Sciences
Burns & Levinson
(Moderator) |
Dipty Desai, PhD
Co-Chair, TiE Global Health
TiE Angels |
Matt Martin, PhD, MBA
Venture Partner
Pathway Bioventures |
|
 |
|
|
Gita Reinitz
Principal (NFX Bio)
NFX |
|
Tuesday, March 22, 4 PM EDT
Tales from the Road: AI Innovators on their Fundraising Journey
 |
 |
 |
Chelsea Sumner, PharmD
NALA Healthcare AI Startups Lead
NVIDIA
(Moderator) |
Davide Vigano
Co-Founder & CEO
Sensoria |
Ramji Srinivasan
Co-Founder & CEO
Teiko.bio |
 |
 |
|
Himanshu Misra, PhD
CEO
Enliten AI |
Leila Pirhaji, PhD
Founder & CEO
ReviveMed |
|
Wednesday, March 23, 10AM EDT
Mental & Behavioral Health Panel
Investing in Technologies that Help Manage Well-Being
 |
 |
 |
Lana Ghanem, MBA
Managing Director
Hikma Ventures |
Raj Pallapothu
Managing Director
Bio 9 Ventures |
Mayank Taneja, MBA
Director, Venture Investments
OSF Healthcare Ventures |
|
 |
|
|
Charlie Hartwell
Operating Partner
Bridge Builders Collaborative |
|
Wednesday, March 23, 11 AM EDT
Age-Tech Devices
Seniors Embrace Innovative Medtech for Better Quality of Life
 |
 |
 |
Lise Pape
Trustee
Future Care Capital |
Rick Robinson
Vice President, Startup Engagement
AARP Innovation Labs |
Clarence Tan, PhD, MBA
Co-Founder
ABBY by GOGOTECH |
Wednesday, March 23, 2 PM EDT
Medtech Strategics
Large Corporations Seeking External Innovation in MedTech
 |
 |
 |
David Uffer
Senior Partner
Alira Health Ventures
(Moderator) |
Lana Caron, MBA
Innovation Lead
Philips Health Technology Ventures |
Juan Cueva, PhD, MBA
Director, New Ventures & Early Innovation Partnering
Johnson & Johnson Innovation |
|
 |
|
|
Tali Hirsch
Director, Venture Investments
Fresenius Medical Care Ventures |
|
Wednesday, March 23, 3 PM EDT
AI Drug Discovery and Development
How AI is Accelerating Therapeutic Advancement
 |
 |
 |
Rafael Rosengarten, PhD
Co-Founder, Board Director & Executive Committee Member
The Alliance for Artificial Intelligence in Healthcare
(Moderator) |
Galym Imanbayev, MD, MBA
Partner
Lightspeed Venture Partners |
Linda Li
Managing Director
Vickers Venture Partners |
|
 |
|
|
Thea Pham, PhD
Associate, Investments
OCV Partners |
|
Wednesday, March 23, 4 PM EDT
Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey
 |
 |
 |
Greg Mannix
VP of International Business Development
Life Science Nation
(Moderator) |
Russell McAllister, MBA
CEO
Bold Therapeutics |
Brian Hess, MBA
CEO
RevBio |
|
 |
|
|
Alan Lucas
Co-Founder, CEO & Director
Navigation Sciences |
|
Thursday, March 24, 11 AM EDT
Precision Medicine
Improving Outcomes through a Patient-Tailored Approach
 |
 |
 |
David Crean
President & CEO
Coast BioVentures |
Niall Kerrigan
Program Manager
Plug and Play Ventures |
Eric de la Fortelle
Managing Partner
Cathay Capital |
Thursday, March 24, 1 PM EDT
Cell & Gene Therapy
The Next Generation of Therapeutic Technologies
 |
 |
 |
Nishta Rao
Managing Director – Life Science
First Republic Bank
(Moderator) |
Cynthia Lavoie
President & Chief Investment Officer
Centre for Commercialization of Regenerative Medicine |
Scott Galasinski
Global Head, Business Development, Licensing & Strategy, Biopharmaceuticals R&D
AstraZeneca |
 |
 |
 |
Megan Krench
Director, Investments
Sanofi Ventures |
Yury Kukushkin
Investment Director
JDRF T1D Fund |
Alicia Yin, PhD
Vice President
6 Dimensions Capital |
Thursday, March 24, 2 PM EDT
Defining AI Investment
AI-Exclusive Investors Share Their Perspectives
 |
 |
 |
Amit Garg, MBA
Co-Founder & Managing Partner
Tau Ventures
(Moderator) |
Navid Alipour, JD, MBA
Managing Partner
Analytics Ventures |
Isabel Fox
General Partner
Outsized Ventures |
|
 |
|
|
Gayathri Radhakrishnan, MBA
Senior Director, Venture Capital – AI Fund
Micron Technology |
|
Thursday, March 24, 4 PM EDT
Tales from the Road: Age-Tech Innovators on their Fundraising Journey
 |
 |
 |
Jackie Marshall-Cyrus
Director
Jackie Marshall-Cyrus & Associates Ltd
(Moderator) |
Char Hu, PhD
Co-Founder & CEO
The Helper Bees |
Meredith Oppenheim
Founder & CEO
Vitality Society |
|
 |
|
|
Kyle Rand
Co-Founder & CEO
Rendever |
|
